Get the latest tech news
Spider venom-inspired peptide to revolutionize sexual dysfunction medicine for both men and women
Another Day Pharma tells us how a spider venom-derived topical peptide might be able to help those affected by erectile dysfunction and female sexual dysfunction.
Here, Carlos Sanchez, Another Day Pharma’s chairman, shares the company’s vision for reviving sexual medicine as a serious therapeutic frontier by explaining the science behind BZ371A, and discusses why he believes the time is right to push past stigma and bring this “first-in-class” therapy to patients and markets around the world. Ultimately, we value partners with therapeutic alignment, demonstrated market access capabilities, a willingness to invest in education and stigma reduction, and a shared commitment to improving the lives of patients and couples affected by sexual dysfunction. Given its localized, non-systemic mode of action and favorable safety profile, BZ731A could emerge as the true equivalent of Viagra for women – addressing a far broader segment of the FSD population than PDE5 inhibitors do for men, which are effective in only around one-third of ED cases.
Or read this on r/technology
